NCT00123591 - Safety and Preliminary Efficacy of Recombinant Activated Factor VII in Subjects With Traumatic Brain Injury | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

May 31, 2006

Study Completion Date

May 31, 2006

Conditions

Acquired Bleeding DisorderTrauma

Interventions

DRUG

activated recombinant human factor VII

Trial Locations (15)

Novo Nordisk Investigational Site, Taoyuan District

Novo Nordisk Investigational Site, Zurich

Novo Nordisk Investigational Site, Hanover

Novo Nordisk Investigational Site, Haifa

Novo Nordisk Investigational Site, Cesena

Novo Nordisk Investigational Site, Ramat Gan

Novo Nordisk Investigational Site, Tel Aviv

Novo Nordisk Investigational Site, New Dehli

Novo Nordisk Investigational Site, Singapore

Novo Nordisk Investigational Site, Singapore

Novo Nordisk Investigational Site, Bangalore

Novo Nordisk Investigational Site, Montreal

Novo Nordisk Investigational Site, Helsinki

Novo Nordisk Investigational Site, Rotterdam

Novo Nordisk Investigational Site, Barcelona